ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36153
-0.01%
Bitcoin
66,251.91
-1.03%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Humanigen Inc (HGEN)

  7. Humanigen Inc (HGEN) News

HGEN

Humanigen (HGEN)

Humanigen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HGEN
DateTimeSourceHeadlineSymbolCompany
01/08/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HGENHumanigen Inc
09/14/20233:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HGENHumanigen Inc
05/15/20235:36AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HGENHumanigen Inc
04/25/20233:06PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:HGENHumanigen Inc
04/19/20235:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
04/06/20233:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
03/13/20235:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
02/01/202312:21PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HGENHumanigen Inc
12/22/20224:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
11/14/20223:44PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HGENHumanigen Inc
11/14/20223:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
10/21/20224:45AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
10/19/20224:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
10/14/20224:45AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
10/12/20224:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
10/07/20224:53AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
10/06/20224:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
09/30/20224:45AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
09/28/20224:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
09/23/20224:45AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
09/21/20224:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
09/16/20224:45AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
09/14/20225:15AMTipRanksH.C. Wainwright Remains a Hold on Humanigen (HGEN)NASDAQ:HGENHumanigen Inc
09/14/20224:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
09/09/20224:45AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
09/07/20224:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
09/02/20223:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
09/02/20224:45AMPR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
08/26/20223:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
08/15/20225:16AMTipRanksHumanigen (HGEN) Gets a Hold from H.C. WainwrightNASDAQ:HGENHumanigen Inc
 Showing the most relevant articles for your search:NASDAQ:HGEN

Your Recent History

EU
B277
L Etat Belge De Belgisch...
COIN
PARGBP
Parachute
COIN
GMTTTETH
BIT
UV8CSJ
UniCredit Bank
LBNK
TONUSDT
Wrapped TON Coin
USOTC
CGOLF
Contact Gold Corporation... (QB)
TSX
GRNI
BMO Brookfield Global Re...
EU
1021T
1021T
TG
APPH
Apontis Pharma
ASX
GGL
EU
IE000CL68Z69
Amundi Asset Management ...
EU
FALG
Fermentalg
BIT
UB87NL
Unicredit Bank
TSXV
HFI
NASDAQ
CCFLX
Principal Mid Cap Portfo...
USOTC
TMNA
Tingo (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved